This WINNER (Week of Indonesia Netherlands Education and Research) event is a follow-up of the Climate Adaptation Summit (CAS), January 2021, and explores forms of cooperation between and within nations to make climate adaptation work for everyone, with a focus on Indonesia and the Netherlands. We will build on the successful international establishment of the Adaptation Action Agenda with high level keynotes. Then, two forms of Indonesia – Netherlands collaboration in urban and rural areas will be highlighted. Finally, we dive into the prerequisites for successful climate adaptation in a session focused on a priority for both the Netherlands and Indonesia: water resilience.
We will build on the successful international establishment of the Adaptation Action Agenda with high level keynotes. Then, two forms of Indonesia – Netherlands collaboration in urban and rural areas will be highlighted. Finally, we dive into the prerequisites for successful climate adaptation in a session focused on a priority for both the Netherlands and Indonesia: water resilience.
The WINNER 2021 conference includes contributions from the Ministers of Education of Indonesia and the Netherlands: Minister Nadiem Anwar Makarim and Minister Ingrid van Engelshoven; keynote speeches from pioneering scientists: Dr. Dwinita Lasarati and Prof. Lisa Becking.
Invitation for Matchmaking
The matchmaking session provides the opportunity for both Indonesian and Dutch government agencies, researchers, Non-Government Organisations, potential investors, entrepreneurs, or even education enthusiasts to introduce their ideas for collaboration- and/or their research projects to search for partners. More information: https://winner.or.id/winner-2021/matchmaking/
Call for Posters
The WINNER Committee is inviting you to take part in the Poster Session by presenting research outcomes or highlighting innovative practices that are aligned with the conference’s overarching theme “Innovation for the SDGs: Education and Research Collaboration towards the future.” Deadline: 15 October. More information: https://winner.or.id/winner-2021/poster-session/
Virtual Expo Study in Indonesia (For students)
Indonesian HEIs will showcase their institutions in the Study in Indonesia Expo. Join the expo to explore higher education in Indonesia and English-taught study programmes or possible research opportunities for international students, focusing on Dutch students. It is also intended for Indonesian HEIs that have (prior) partnerships with Dutch HEIs and an established International (Relations) Office.
The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11. Developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre (LUMC), it is the fourth vaccine to be administered in the European Union. The Netherlands has ordered more than 11 million vaccine doses.
For many students from the LUMC’s academic programmes, studying abroad is an indispensable experience. Doing part of your studies abroad is a special experience, not only because of the sense of adventure of being abroad, also to develop a broader perspective on Life Sciences & Health, a highly international field. So, you can imagine the LUMC’s International Office’s struggle to have to tell students ‘no’ for a study experience abroad in the midst of the corona pandemic. In addition, the many lockdowns worldwide increased the workload dramatically for the International Office. Evelien Hack, Head of the International Office and Sandra van Deursen, senior administrative assistant, share how corona has impacted studying abroad.
The Leiden University Medical Center (LUMC) and Ixaka Ltd. have announced a research collaboration on 30 March 2021, to better understand REX-001, Ixaka’s lead cell therapy product. The project will be led by Professor Paul Quax, Head of Experimental Vascular Surgery at the LUMC, to support accelerated development of REX-001 in Phase III clinical trials for the treatment of chronic limb-threatening ischemia (CLTI).